Document is current
Any future updates will be listed below
-
Authors
Fernández, Ana
Salgado, Mercedes
García, Adelaida
Buxò, Elvira
Vera, Ruth
Adeva, Jorge
Jiménez-Fonseca, Paula
Quintero, Guillermo
Llorca, Cristina
Cañabate, Mamen
López, Luis Jesús
Muñoz, Andrés
Ramírez, Patricia
González, Paula
López, Carlos
Reboredo, Margarita
Gallardo, Elena
Sanchez-Cánovas, Manuel
Gallego, Javier
Guillén, Carmen
Ruiz-Miravet, Nuria
Navarro-Pérez, Víctor
De la Cámara, Juan
Alés-Díaz, Inmaculada
Pazo-Cid, Roberto Antonio
Carmona-Bayonas, Alberto
-
Funding
Funding for this research was provided by:
Galician Group for Research on Gastrointestinal Tumors
Celgene
- License Information
-
More Information
Article History
Received: 20 September 2018
Accepted: 16 November 2018
First Online: 29 November 2018
Ethics approval and consent to participate
: The study was approved by the ethics committee of the autonomous community of Galicia (SERGAS) (Spain). All patients provided written informed consent before data collection.
: Not applicable.
: AG has received a grant for attending an international oncology congress and fees as scientific consultant from Celgene. AM has received research support grants and fees as consultant from Celgene, and fees as speaker from Shire. CL2 has received fees as speaker and consultant from Celgene. AF, MS, EB, RV, JA, PJ, GQ, CL1, LJL, PR, PG, MR, EG, MSC, AC, JG, CG, NR, VN, JC, IA, RAP declare that they have no conflicts of interest regarding the content of this manuscript.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
